Member’s Publications

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V W  X  Y  Z


A

Aad, Simon Abi. Our Patients’ Care Comes First, Even During National Disasters. 08 April 2018.

Aghajanian Carol, Chen Lee-may, Darus Christopher J., Filiaci Virginia L., Makker Vicky, Moxley Katherine, Sutton Gregory. Phase II evaluation of dalantercept, a soluble recombinant activin receptor-like kinase 1 (ALK1) receptor fusion protein, for the treatment of recurrent or persistent endometrial cancer: An NRG Oncology/Gynecologic Oncology Group Study 0229N. 16 April 2015.

Ahmad Sarfraz, Ali Ghazanfar, Banks Robert K., Edwards John R., Finkler Neil J., Holloway Robert W., Ingersoll Susan B., McGann Hasina C., Srivastava Milan, Stavitzski Nicole M.. Cellular therapy in combination with cytokines improves survival in a xenograft mouse model of ovarian cancer. Springer Science+Business Media New York 2015. Published online: 6 June 2015

Ahmad Sarfraz, Ph.D., Ansari Ammara, M.D., Holloway Robert W., M.D., James Jeffery A., D.O., Jeppson Corinne N., D.O., Robotic-assisted Laparoscopic Resection of Cornual Ectopic Pregnancy: A Case Report. The Journal of Reproductive Medicine. Volume 60, Number 1-2/January-February 2015.

Ahmad S., Boggess  J.F., Dahl A.A., Holloway R.W., Jackson A.L., Sert B.M., Stavitzski, N.M. Robot-assisted versus open radical hysterectomy: A multi-institutional experience for early-stage cervical cancer. December 2015.

Ahmad Sarfraz, Chen Ping, Han Lingfei, Li Fang, Lu Jiahong, Kong Fanfei, Ma Ge, Sun Jing, Tao Jie, Wang Wei, Shuai Wen, Ye Lei, Zhao Dong, Zhou Qian, Zhu Jianlong, Zhu Yiping. AAV–sBTLA facilitates HSP70 vaccine-triggered prophylactic antitumor immunity against a murine melanoma pulmonary metastasis model in vivo. Cancer Letters Volume 354, Issue 2, Pages 398–406. August 18, 2014.

Ahmad Sarfraz PhD, Conri Vanessa, MD,Fastrez Maxime, MD, Goffin Frederic, MD, Holloway Robert, MD, Hudry Delphine, MD, Lambaudie Eric, MD, PhD, Le ́curu Fabrice, MD, PhD,Leguevaque Pierre, MD, PhD, Narducci Fabrice, MD, Ponce Jordi, MD, PhD, Tucher Elisabeth, MD, Zanagnolo Vanna, MD with the collaboration of the SERGS Group. Robotically Assisted Para-aortic Lymphadenectomy: Surgical Results A Cohort Study of 487 Patients. International Journal of Gynecological Cancer & Volume 25, Number 3, March 2015.

Ahmad Sarfraz, PhD, Gupta Sarika, MD, Holloway Robert W., MD, Wisner Ketura Preya A., DO. Indications and Techniques for Robotic Pelvic and Para-Aortic Lymphadenectomy in Gynecologic Oncology. Journal of Surgical Oncology 2015;112:782–789.

Ahmad Sarfraz, Holloway Robert W., James Jeffrey A., Jeppson Corinne N., Rakowski Joseph A., Stavitzski Nicole M.. Robotic transperitoneal infra-renal aortic lymphadenectomy in early-stage endometrial cancer. Gynecologic Oncology 136 (2015) 285–292. 27 December 2014.

Ahmad Sarfraz, Kendrick James E. and Holloway Robert W.. Robotic pelvic and aortic lymphadenectomy for gynecologic malignancies – one approach. Bereitgestellt von | De Gruyter / TCS Angemeldet | 46.30.84.116.

Akerley Wallace L., MD, Berek Jonathan S., MD, DeMars Leslie R., MD, Edwards Robert P., MD, Friccius-Quecke Hilke, PhD, Herzog Thomas J., MD, Holloway Robert W., MD, Krasner Carolyn N., MD, Lentz Samuel S., MD, Method Michael W., MD, MPH, MBA, Morris Robert T., MD, Parker Lynn P., MD, Plaxe Steven C., MD, Walker Joan L., MD. Catumaxomab for the Treatment of Malignant Ascites in Patients With Chemotherapy-Refractory Ovarian Cancer: A Phase II Study. International Journal of Gynecological Cancer & Volume 24, Number 9. November 2014.

Al-Badawi IA, Alshankiti H, Ahmad S. Single incision laparoscopic surgery in pregnancy. CRSLS e2014.00404. DOI: 10.4293/CRSLS.2014.00404.

C

Caglevic C, Grassi M, Raez LE, Listi A, Giallombardo M, Bustamante E, Gil-Bazo I, Rolfo C. Nintedanib in non-small cell lung cancer: from preclinical to approval. Ther Adv Respir Dis. 2015 Apr 7. pii: 1753465815579608. [Epub ahead of print] Review.

Chan J. K., Fiorica J. V., Grendys Jr.E. C., Herzog T. J., Holloway R., Orr Jr. J. W.,Tian C., Wang D.. Overview of a chemoresponse assay in ovarian cancer. Clin Transl Oncol (2014) 16:761–769. 2 July 2014.

ChristianRolfoMD, PhD, MBA Philip C.MackPhD Giorgio V.ScagliottiMD, PhD PaulBaasMD, PhD FabriceBarlesiMD, PhD Trever G.BivonaMD, PhD Roy S.HerbstMD, PhD Tony S.MokMDhNirPeledMD, PhDiRobertPirkerMD Luis E.RaezMD MartinReckMD, PhD Jonathan W.RiessMD Lecia V.SequistMD, MPH Frances A.ShepherdMD Lynette M.ShollMD Daniel SW.Tan MBBS, PhD Heather A.WakeleeMD Ignacio I.WistubaMD Murry W.WynesPhD David P.CarboneMD, PhD Fred R.Hirsch.MD, PhD David R.GandaraMD IASLC Statement Paper: Liquid Biopsy for Advanced Non-Small Cell Lung Cancer (NSCLC). 6 June 2018.

Cohen EE, Karrison TG, Kocherginsky M, Mueller J, Egan R, Huang CH, Brockstein BE, Agulnik MB, Mittal BB, Yunus F, Samant S, Raez LE, Mehra R, Kumar P, Ondrey F, Marchand P, Braegas B, Seiwert TY, Villaflor VM, Haraf DJ, Vokes EE. Phase III randomized trial of induction chemotherapy in patients with N2 or N3 locally advanced head and neck cancer. J Clin Oncol. 2014 Sep 1; 32(25):2735-43. doi: 10.1200/JCO.2013.54.6309. Epub 2014 Jul 21.PMID:25049329

F

Finkler Neil, Fong Peter C, Garcia Agustin A, Konecny Gottfried E, Kristeleit Rebecca, Mishra Kaushal, Lee Paula S, Lorusso Domenica, Rocconi Rodney P, Squires Matt, Upalawanna Allison, Wang Yongyu. Second-line dovitinib (TKI258) in patients with FGFR2-mutated or FGFR2-non-mutated advanced or metastatic endometrial cancer: a non-randomised, open-label, two-group, two-stage, phase 2 study. www.thelancet.com/oncology Vol 16 June 2015.

G

Gubbi Ajit, Finkler Neil J., Kendrick James E.. The role of bevacizumab in recurrent, platinum-sensitive ovarian cancer. Expert review of anticancer therapy 14.10 (2014): 1105-1113.

H

Holloway Robert W., Ahmad Sarfraz, Bigsby Glenn E., Brudie Lorna A., Gubbi Ajit, Gupta Sarika, Stavitzski Nicole M., Takimoto Erica L. Zhu Xiang. Sentinel lymph node mapping with staging lymphadenectomy for patients with endometrial cancer increases the detection of metastasis. January 2016.

Hakam A, Armstrong DK, Alvarez RD, Bakkum-Gamez JN, Barroilhet L, Behbakht K, Berchuck A, Berek JS, Chen LM, Cristea M, DeRosa M, ElNaggar AC, Gershenson DM, Gray HJ, Jain A, Johnston C, Leath CA III, Liu J, Mahdi H, Matei D, McHale M, McLean K, O’Malley DM, Penson RT, Percac-Lima S, Ratner E, Remmenga SW, Sabbatini P, Werner TL, Zsiros E, Burns JL, Engh AM.  NCCN Guidelines Insights: Ovarian Cancer, Version 1.2019. J Natl Compr Canc Netw. 2019 Aug 1;17(8):896-909. doi: 10.6004/jnccn.2019.0039.  PMID: 31390583 [PubMed – in process]

Hakam A, Nguyen L, Khazai L, Centeno BA, Rosa M.  Diagnostic value of intraoperative rapid cytokeratin immunostain in the cytological evaluation of sentinel lymph nodes in patients with invasive lobular carcinoma. Diagn Cytopathol. 2019 May;47(5):482-487. doi: 10.1002/dc.24141. Epub 2018 Dec 27.  PMID: 30589516 [PubMed – indexed for MEDLINE]

Hakam A, Matsuo K, Takazawa Y, Ross MS, Elishaev E, Yunokawa M, Sheridan TB, Bush SH, Klobocista MM, Blake EA, Takano T, Baba T, Satoh S, Shida M, Ikeda Y, Adachi S, Yokoyama T, Takekuma M, Yanai S, Takeuchi S, Nishimura M, Iwasaki K, Johnson MS, Yoshida M, Machida H, Mhawech-Fauceglia P, Ueda Y, Yoshino K, Kajiwara H, Hasegawa K, Yasuda M, Miyake TM, Moriya T, Yuba Y, Morgan T, Fukagawa T, Pejovic T, Nagano T, Sasaki T, Richmond AM, Post MD, Shahzad MMK, Im DD, Yoshida H, Omatsu K, Ueland FR, Kelley JL, Karabakhtsian RG, Roman LD.  Characterizing sarcoma dominance pattern in uterine carcinosarcoma: Homologous versus heterologous element. Surg Oncol. 2018 Sep;27(3):433-440. doi: 10.1016/j.suronc.2018.05.017. Epub 2018 May 11.  PMID: 30217299 [PubMed – indexed for MEDLINE]

Hakam A, Matsuo K, Takazawa Y, Ross MS, Elishaev E, Yunokawa M, Sheridan TB, Bush SH, Klobocista MM, Blake EA, Takano T, Baba T, Satoh S, Shida M, Ikeda Y, Adachi S, Yokoyama T, Takekuma M, Yanai S, Takeuchi S, Nishimura M, Iwasaki K, Johnson MS, Yoshida M, Machida H, Mhawech-Fauceglia P, Ueda Y, Yoshino K, Kajiwara H, Hasegawa K, Yasuda M, Miyake TM, Moriya T, Yuba Y, Morgan T, Fukagawa T, Pejovic T, Nagano T, Sasaki T, Richmond AM, Post MD, Shahzad MMK, Im DD, Yoshida H, Enomoto T, Omatsu K, Ueland FR, Kelley JL, Karabakhtsian RG, Roman LD.  Proposal for a Risk-Based Categorization of Uterine Carcinosarcoma. Ann Surg Oncol. 2018 Nov;25(12):3676-3684. doi: 10.1245/s10434-018-6695-z. Epub 2018 Aug 13.  PMID: 30105438 [PubMed – indexed for MEDLINE]

Hakam A, Jeong D, Abuel-Haija M, Chon HS.  Ovarian microcystic stromal tumor: Radiologic-pathologic correlation. Gynecol Oncol Rep. 2018 May 8;25:11-14. doi: 10.1016/j.gore.2018.05.004. eCollection 2018 Aug.  PMID: 30014019 [PubMed] Free PMC Article

Hakam A, Matsuo K, Takazawa Y, Ross MS, Elishaev E, Yunokawa M, Sheridan TB, Bush SH, Klobocista MM, Blake EA, Takano T, Baba T, Satoh S, Shida M, Ikeda Y, Adachi S, Yokoyama T, Takekuma M, Yanai S, Takeuchi S, Nishimura M, Iwasaki K, Johnson MS, Yoshida M, Machida H, Mhawech-Fauceglia P, Ueda Y, Yoshino K, Kajiwara H, Hasegawa K, Yasuda M, Miyake TM, Moriya T, Yuba Y, Morgan T, Fukagawa T, Pejovic T, Nagano T, Sasaki T, Richmond AM, Post MD, Shahzad MMK, Im DD, Yoshida H, Enomoto T, Omatsu K, Ueland FR, Kelley JL, Karabakhtsian RG, Roman LD.  Significance of Lymphovascular Space Invasion by the Sarcomatous Component in Uterine Carcinosarcoma. Ann Surg Oncol. 2018 Sep;25(9):2756-2766. doi: 10.1245/s10434-018-6547-x. Epub 2018 Jul 3.  PMID: 29971677 [PubMed – indexed for MEDLINE]

Hakam A, Kuznicki ML, Robertson SE, Shahzad MM.  Metastatic uterine tumor resembling ovarian sex cord tumor: A case report and review of the literature. Gynecol Oncol Rep. 2017 Sep 29;22:64-68. doi: 10.1016/j.gore.2017.09.012. eCollection 2017 Nov.  PMID: 29034309 [PubMed] Free PMC Article

Hakam A, Saglam O, Xiong Y, Marchion DC, Strosberg C, Wenham RM, Johnson JJ, Saeed-Vafa D, Cubitt C, Magliocco AM.  ERBB4 Expression in Ovarian Serous Carcinoma Resistant to Platinum-Based Therapy. Cancer Control. 2017 Jan;24(1):89-95.  PMID: 28178720 [PubMed – indexed for MEDLINE]

Hakam A, Morgan RJ Jr, Armstrong DK, Alvarez RD, Bakkum-Gamez JN, Behbakht K, Chen LM, Copeland L, Crispens MA, DeRosa M, Dorigo O, Gershenson DM, Gray HJ, Havrilesky LJ, Johnston C, Lele S, Martin L, Matulonis UA, O’Malley DM, Penson RT, Percac-Lima S, Pineda M, Plaxe SC, Powell MA, Ratner E, Remmenga SW, Rose PG, Sabbatini P, Santoso JT, Werner TL, Burns J, Hughes M.  Ovarian Cancer, Version 1.2016, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2016 Sep;14(9):1134-63.  PMID: 27587625 [PubMed – indexed for MEDLINE]

Hakam A, Ahdallah R, Morse B, Shahzad MM.  Pelvic squamous cell carcinoma of unknown primary: a case report and review of the literature. Eur J Gynaecol Oncol. 2016;37(3):430-3. Review.  PMID: 27352581 [PubMed – indexed for MEDLINE]

Hakam A, Matsuo K, Takazawa Y, Ross MS, Elishaev E, Podzielinski I, Yunokawa M, Sheridan TB, Bush SH, Klobocista MM, Blake EA, Takano T, Matsuzaki S, Baba T, Satoh S, Shida M, Nishikawa T, Ikeda Y, Adachi S, Yokoyama T, Takekuma M, Fujiwara K, Hazama Y, Kadogami D, Moffitt MN, Takeuchi S, Nishimura M, Iwasaki K, Ushioda N, Johnson MS, Yoshida M, Li SW, Richmond AM, Machida H, Mhawech-Fauceglia P, Ueda Y, Yoshino K, Yamaguchi K, Oishi T, Kajiwara H, Hasegawa K, Yasuda M, Kawana K, Suda K, Miyake TM, Moriya T, Yuba Y, Morgan T, Fukagawa T, Wakatsuki A, Sugiyama T, Pejovic T, Nagano T, Shimoya K, Andoh M, Shiki Y, Enomoto T, Sasaki T, Fujiwara K, Mikami M, Shimada M, Konishi I, Kimura T, Post MD, Shahzad MM, Im DD, Yoshida H, Omatsu K, Ueland FR, Kelley JL, Karabakhtsian RG, Roman LD.  Significance of histologic pattern of carcinoma and sarcoma components on survival outcomes of uterine carcinosarcoma. Ann Oncol. 2016 Jul;27(7):1257-66. doi: 10.1093/annonc/mdw161. Epub 2016 Apr 6.  PMID: 27052653 [PubMed – indexed for MEDLINE]

Hakam A, Siegel EM, Riggs BM, Delmas AL, Koch A, Brown KD.  Quantitative DNA methylation analysis of candidate genes in cervical cancer. PLoS One. 2015 Mar 31;10(3):e0122495. doi: 10.1371/journal.pone.0122495. eCollection 2015.  PMID: 25826459 [PubMed – indexed for MEDLINE] Free PMC Article

Hakam A, Stickles XB, Marchion DC, Bicaku E, Al Sawah E, Abbasi F, Xiong Y, Bou Zgheib N, Boac BM, Orr BC, Judson PL, Berry A, Wenham RM, Apte SM, Berglund AE, Lancaster JM.  BAD-mediated apoptotic pathway is associated with human cancer development. Int J Mol Med. 2015 Apr;35(4):1081-7. doi: 10.3892/ijmm.2015.2091. Epub 2015 Feb 5.  PMID: 25653146 [PubMed – indexed for MEDLINE] Free PMC Article

K

Kelkar MD, Amar H. An Outbreak of Synthetic Cannabinoid–Associated Coagulopathy in Illinois New England Journal of Medicine.

M

Mallen AR, Townsend MK, Tworoger SS. Risk factors for ovarian carcinoma. Hematol Oncol Clin North Am. 2018 Dec; 32(6): 891-902. PMID: 30390763

Mallen AR, Soong R, Townsend MK, Wenham RM, Crum CP, Tworoger SS. Surgical prevention strategies in ovarian cancer. Gynecol Oncol. 2018 Oct; 151 (1):166-175. PMID: 30087058.

Marks, Alan The Physician’s Perspective: A Health Policy Brief on Improving Patient Access to Immuno-Oncology Therapies. The Institute for Patient Access Dis. 2015 October.

Marks, Alan, Iyengar, Sloka. The Physician’s Perspective: A Health Policy on Improving Cancer Patient’s Access to Precision Medicine. The Institute for Patient Access Dis. 2016 May.

P

Passiglia F, Van Der Steen N, Raez LE, Pauwels P, Gil-Bazo I, Santos E, Santini D, Tesoriere G, Russo A, Bronte G, Zwaenepoel K, Cappuzzo F, Rolfo C. The role of cMet in non-small cell lung cancer resistant to EGFR-inhibitors: did we really find the target? Curr Drug Targets. 2014;15(14):1284-92. Review.

Perez CA, Velez M, Raez LE, Santos ES. Overcoming the resistance to Crizotinib in patients with Non-Small Cell Lung Cancer harboring EML4/ALK translocation. Lung Cancer. 2014 Feb 8. pii: S0169-5002(14)00064-6. doi: 10.1016/j.lungcan.2014.02.001. [Epub ahead of print] Review.

R

Raez, Luis E. “Patient-Centered Standards for Medically Integrated Dispensing: ASCO/NCODA Standards.” Journal of Clinical Oncology, 13 Dec. 2019,  https://ascopubs.org/doi/pdfdirect/10.1200/JCO.19.02297.

Raez, Luis E. “Efficacy of Larotrectinib in TRK Fusion–Positive Cancers in Adults and Children.” The New England Journal of Medicine, 22 Feb. 2018, www.nejm.org/doi/full/10.1056/NEJMoa1714448.

Rolfo C, Giovannetti E, Hong DS, Bivona T, Raez LE, Bronte G, Buffoni L, Reguart N, Santos ES, Germonpre P, Taron M, Passiglia F, Van Meerbeeck JP, Russo A, Peeters M, Gil-Bazo I, Pauwels P, Rosell R. Novel therapeutic strategies for patients with NSCLC that do not respond to treatment with EGFR inhibitors. Cancer Treat Rev. 2014 Sep; 40(8):990-1004. doi: 10.1016/j.ctrv.2014.05.009. Epub 2014 Jun 6. Review. PMID: 24953979

Rolfo C, Passiglia F, Castiglia M, Raez LE, Germonpre P, Gil-Bazo I, Zwaenepoel K, De Wilde A, Bronte G, Russo A, Van Meerbeeck JP, Van Schil P, Pauwels P. ALK and crizotinib: after the honeymoon…what else? Resistance mechanisms and new therapies to overcome it. Transl Lung Cancer Res. 2014 Aug;3(4):250-61. doi: 10.3978/j.issn.2218-6751.2014.03.01. Review

Rolfo C, Sortino G, Smits E, Passiglia F, Bronte G, Castiglia M, Russo A, Santos ES, Janssens A, Pauwels P, Raez LE. Immunotherapy: is a minor god yet in the pantheon of treatments for lung cancer? Expert Rev Anticancer Ther. 2014 Oct;14(10):1173-87. doi: 10.1586/14737140.2014.952287. Epub 2014 Aug 22. PMID: 25148289.

Rolfo C, Ruiz R, Giovannetti E, Gil-Bazo I, Russo A, Passiglia F, Giallombardo M, Peeters M, Raez LE. Entrectinib: a potent new TRK, ROS1, and ALK inhibitor. Expert Opin Investig Drugs. 2015 Nov;24(11):1493-500. doi: 10.1517/13543784.2015.1096344.Epub 2015 Oct 12. PMID:26457764.

Ruiz R, Hunis B, Raez LE. Immunotherapeutic agents in non-small-cell lung cancer finally coming to the front lines. Curr Oncol Rep. 2014 Sep; 16(9):400. doi: 10.1007/s11912-014-0400-6. PMID: 25030654.

Ruiz R, Raez LE, Rolfo C. Entinostat (SNDX-275) for the treatment of non-small cell lung cancer.  Expert Opin Investig Drugs. 2015;24(8):1101-9. doi: 10.1517/13543784.2015.1056779. Epub 2015 Jun 22. PMID: 26098363

S

Santos Castillero, Edgardo S. “Lung Cancer Surveillance After Definitive Curative-Intent Therapy: ASCO Guideline.” Journal of Clinical Oncology, December 12, 2019, https://www.asco.org/research-guidelines/quality-guidelines/guidelines/thoracic-cancer#/142246 doi: 10.1200/JCO.19.02748.

V

Van Der Steen N, Pauwels P, Gil-Bazo I, Castañon E, Raez LE, Cappuzzo F, Rolfo C. cMET in NSCLC: Can We Cut off the Head of the Hydra? From the Pathway to the Resistance. Cancers (Basel). 2015 Mar 25;7(2):556-73. doi: 10.3390/cancers7020556. Review. PMID:25815459.

© 2020 FLASCO | Premium Website Design by The HDG

FLASCO